SANVO Fine Chemicals Group Limited

HKEX:0301.HK

1.11 (HKD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q32017 Q22016 Q42016 Q32016 Q22015 Q4
Revenue 507.946556.546520.243486.588461.262519.966463.141498.201341.788442.662371.354450.563318.608192.293167.319334.637167.319128.055256.11128.055
Cost of Revenue 352.926400.762364.09355.293331.568386.04335.144331.131239.915331.249258.235327.182256.177145.84129.085258.169129.08594.619189.23894.619
Gross Profit 155.02155.784156.153131.295129.694133.926127.997167.07101.873111.413113.119123.38162.43146.45338.23476.46838.23433.43666.87233.436
Gross Profit Ratio 0.3050.280.30.270.2810.2580.2760.3350.2980.2520.3050.2740.1960.2420.2290.2290.2290.2610.2610.261
Reseach & Development Expenses 051.631042.175041.169036.648036.706017.47910.3736.9634.3958.794.3952.6185.2372.618
General & Administrative Expenses 70.14480.82461.66262.20955.17463.53546.82552.48339.96543.19737.62836.63225.1064.9843.5317.0613.5312.1234.2462.123
Selling & Marketing Expenses 83.30678.94471.59871.56660.24471.97457.43360.80642.91953.29248.84352.10338.13522.5618.17836.35618.17815.01330.02515.013
SG&A 153.45167.109132.966134.59115.418139.666104.258114.00382.88497.14986.47188.73563.24127.54421.70843.41721.70817.13634.27117.136
Other Expenses 00000000000005.2884.3718.7424.3714.5939.1874.593
Operating Expenses 153.45218.74130.12133.876111.326138.119102.849111.57581.166101.00192.7191.26962.21639.79530.47460.94830.47424.34748.69424.347
Operating Income 1.57-62.95623.187-3.29514.276-5.7423.73953.06718.98914.26426.64834.646-0.818.5477.54115.0827.5418.8817.768.88
Operating Income Ratio 0.003-0.1130.045-0.0070.031-0.0110.0510.1070.0560.0320.0720.077-0.0030.0440.0450.0450.0450.0690.0690.069
Total Other Income Expenses Net 1.13851.939-0.64-1.689-0.225-0.244-1.9472.845-1.24-5.792-8.396-3.8047.867-1.665-1.456-2.913-1.456-1.594-3.189-1.594
Income Before Tax 2.708-11.01722.547-4.98414.051-5.98421.79255.91217.7498.47218.25230.842-3.3166.8826.08512.176.0857.28614.5727.286
Income Before Tax Ratio 0.005-0.020.043-0.010.03-0.0120.0470.1120.0520.0190.0490.068-0.010.0360.0360.0360.0360.0570.0570.057
Income Tax Expense 1.8812.432.8430.2134.3620.6982.4915.0262.8151.2131.5764.5320.261.1980.9831.9670.9831.2412.4811.241
Net Income 0.823-13.4919.704-5.1979.689-5.28619.30150.88614.9347.25916.67626.31-1.9775.6845.10210.2035.1026.04512.0916.045
Net Income Ratio 0.002-0.0240.038-0.0110.021-0.010.0420.1020.0440.0160.0450.058-0.0060.030.030.030.030.0470.0470.047
EPS 0.002-0.0290.042-0.0110.021-0.0110.0410.110.0320.020.045000.0130.0120.0240.0120.0140.0280.014
EPS Diluted 0.002-0.0280.042-0.0110.021-0.0110.0410.110.0320.020.045000.0130.0120.0240.0120.0140.0280.014
EBITDA 6.947-4.88227.482.11418.5961.87326.89759.23622.61318.8131.01138.9381.0510.5638.47916.9588.4799.66719.3349.667
EBITDA Ratio 0.014-0.0090.0530.0040.040.0040.0580.1190.0660.0420.0840.0860.0030.0550.0510.0510.0510.0750.0750.075